Table 2

Univariable and multivariable hazards of incident diabetes

 Univariable analysisMultivariable analysis
HR95% CIp ValueHR95% CIp Value
SVR (Ref—no)
 Yes0.560.45 to 0.68<0.0010.600.48 to 0.74<0.001
Age (years) (Ref—≤50)
 >501.351.13 to 1.620.0011.241.03 to 1.490.02
Gender (Ref—female)
 Male1.190.75 to 1.880.460.890.55 to 1.420.61
Race (Ref—Caucasian)
 African-American1.231.00 to 1.510.061.190.95 to 1.480.13
 Others1.040.80 to 1.350.781.090.84 to 1.420.53
Ethnicity (ref—NH/L)
 Hispanic/Latino1.000.78 to 1.310.961.010.77 to 1.320.96
Body mass index (Ref—<30)
 ≥30 kg/m21.901.60 to 2.24<0.0011.711.44 to 2.03<0.001
ALT (Ref—≤40)
 >40 IU/L1.150.93 to 1.420.211.030.83 to 1.280.82
Glucose (Ref—<100)
 ≥100 mg/dL2.382.00 to 2.84<0.0012.131.78 to 2.54<0.001
HDL (Ref—<40)
 ≥40 mg/dL0.740.63 to 0.88<0.0010.870.72 to 1.040.12
Triglyceride (Ref—<150)
 ≥150 mg/dL1.471.24 to 1.75<0.0011.331.12 to 1.60<0.01
Hypertension (Ref—no)
 Yes1.471.22 to 1.76<0.0011.281.07 to 1.54<0.01
FIB4-score (Ref—≤3.25)
 >3.251.651.35 to 2.01<0.011.491.21 to 1.83<0.001
Genotype (Ref—1)
 20.810.63 to 1.050.111.060.81 to 1.390.68
 30.730.51 to 1.050.090.940.65 to 1.370.75
  • ALT, alanine transaminase; HDL, high-density lipoprotein; NH/L, non-Hispanic/Latino; SVR, sustained virological response.